[1]
A. Sabry, S. et al. 2022. Relationship of the quality of life in capecitabine-treated colorectal cancer patients to sociodemographic characteristics and drug-related adverse effects. Journal of the Faculty of Medicine Baghdad. 64, 3 (Oct. 2022), 175–182. DOI:https://doi.org/10.32007/jfacmedbagdad.6431970.